CVE-2026-3401 identifies a session expiration vulnerability in SourceCodester's Web-based Pharmacy Product Management System version 1.0. The weakness allows an attacker to manipulate session expiration remotely, potentially causing premature session termination or session management inconsistencies. The exact affected component within the system is unspecified, but the flaw relates to session lifecycle handling. The attack vector is network-based (remote), requiring low privileges and no user interaction, but the attack complexity is high, indicating that exploitation demands significant effort or specific conditions. The vulnerability does not compromise confidentiality or availability directly but may impact session integrity to a limited extent. The CVSS 4.0 vector (AV:N/AC:H/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P) reflects a low base score of 2.3, emphasizing the limited impact and difficulty. No patches or mitigations have been officially released, and no active exploitation has been observed. The vulnerability disclosure is recent (March 2026), and the exploit code is publicly available, which could increase risk over time if not addressed.

The primary impact of this vulnerability is limited disruption to session management within the affected pharmacy product system. Organizations could experience premature session expiration or session inconsistencies, potentially leading to user inconvenience or workflow interruptions. Since the vulnerability does not allow privilege escalation, data leakage, or denial of service, the confidentiality, integrity, and availability impacts are minimal. However, in healthcare environments where session continuity is critical for operational efficiency and patient safety, even minor disruptions could have secondary effects. The high attack complexity and lack of known active exploitation reduce immediate risk, but the public availability of exploit code means attackers with sufficient resources might attempt targeted attacks. Overall, the impact is low but should not be ignored in sensitive healthcare contexts.

Organizations using SourceCodester Web-based Pharmacy Product Management System version 1.0 should implement the following mitigations: 1) Monitor vendor communications closely for official patches or updates addressing this vulnerability and apply them promptly. 2) Review and strengthen session management configurations, including session timeout settings and secure cookie attributes, to minimize session-related risks. 3) Employ network-level controls such as web application firewalls (WAFs) to detect and block suspicious session manipulation attempts. 4) Conduct regular security assessments and penetration testing focused on session handling to identify and remediate weaknesses. 5) Educate system administrators and users about the importance of logging out properly and recognizing session anomalies. 6) Consider isolating or segmenting the affected system within the network to limit exposure. These steps provide layered defense beyond generic advice and address the specific nature of the session expiration weakness.